Screener
Amphastar Pharmaceuticals AMPH Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Amphastar Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The source filing: Amphastar Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:50 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001297184-26-000047
FAQ
- What is Amphastar Pharmaceuticals's asset turnover?
- Amphastar Pharmaceuticals (AMPH) reported asset turnover of 0.4× in Q2 2026.
- How has Amphastar Pharmaceuticals's asset turnover changed year-over-year?
- Amphastar Pharmaceuticals's asset turnover decreased by 6.6% year-over-year, from 0.5× to 0.4×.
- What is the long-term trend for Amphastar Pharmaceuticals's asset turnover?
- Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's asset turnover has grown at a -4.8% compound annual growth rate (CAGR), from 0.6× to 0.4×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.
Ask your AI about Amphastar Pharmaceuticals's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude